Minocycline hydrochloride
Thông số
13614-98-7Số CAS
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochlorideTên IUPAC
C23H28ClN3O7Công thức hóa học
493.9 g/molKhối lượng phân tử
MINOCYCLINE HYDROCHLORIDE; 13614-98-7; Minocycline HCl; Arestin; Minomycin; Minocin; Solodyn; Dynacin; Periocline; Ximino; Vectrin; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; Minocycline (hydrochloride); Minomax; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride; DTXSID8044545; MFCD00083669; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride; Mynocine hydrochloride; Minocycline (as hydrochloride); NSC 141993; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride; 0020414E5U; Tri-mino; NSC-141993; C23H28ClN3O7; DTXCID6024545; Acnez; Minomycin chloride; (4S-(4alpha,4aalpha,5aalpha,12aalpha))-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; EINECS 237-099-7; Minocycline hydrochloride (internal use); Lederderm; Mynocine; UNII-0020414E5U; NCGC00096006-01; Prestwick_626; Arestin (TN); Dynacin (TN); Minocin (TN); Solodyn (TN); Minocycline hydrochloride [USP:JAN]; Minocyclinhydrochlorid; AMZEEQ; EMROSI; MINOLIRA; ZILXI; minomycin hydrochloride; SCHEMBL2537; CAS-13614-98-7; Minocycline hydrochloride CRS; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; MLS002548863; SPECTRUM1500414; FXFM-244; orb1226450; orb1309771; orb3139885; CHEMBL1200881; SCHEMBL27275823; MSK4104; HMS1568P12; Pharmakon1600-01500414; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride;[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; Tox21_111250; Tox21_113183; Tox21_301590; CCG-40107; EBC-99036; HB4617; HY-17412R; NSC757120; s4226; MINOCYCLINE HYDROCHLORIDE [MI]; Minocycline hydrochloride, crystalline; AKOS015951312; Minocycline for system suitability CRS; Minocycline hydrochloride (JP18/USP); Tox21_111250_1; AM11587; CS-1256; Minocycline (hydrochloride) (Standard); MINOCYCLINE HYDROCHLORIDE [JAN]; NC00460; NSC-757120; MINOCYCLINE HYDROCHLORIDE [MART.]; MINOCYCLINE HYDROCHLORIDE [VANDF]; NCGC00178854-03; NCGC00255988-01; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride; AC-22362; AK183886; AS-75306; DA-75552; HY-17412; MINOCYCLINE HYDROCHLORIDE [USP-RS]; MINOCYCLINE HYDROCHLORIDE [WHO-DD]; PD003090; SMR001906766; SY007836; M2288; M3353; NS00076430; D00850; MINOCYCLINE HYDROCHLORIDE [ORANGE BOOK]; SBI-0051449.0002; MINOCYCLINE HYDROCHLORIDE [USP MONOGRAPH]; SR-01000075625; SR-01000075625-1; Q27104777; Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard; Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Minocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard; (4S,12aS,4aS,5aR)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide Hydrochloride; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide hydrochloride; (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide--hydrogen chloride (1/1); (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aR,12aS)-; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, MONOHYDROCHLORIDE, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; Minocycline Hydrochloride HydrateTên gọi khác
Sản phẩm chứa Minocycline hydrochloride
페리메디치과용연고(미노사이클린염산염이수화물, 메트로니다졸벤조산염)미노젠캡슐50밀리그램(미노사이클린염산염)미노클캡슐50밀리그램(미노사이클린염산염)미노덴치과용연고(미노사이클린염산염)트리톤치과용연고(미노사이클린염산염)미노큐어치과용연고(미노사이클린염산염)페리오클린치과용연고(미노사이클린염산염)미노클린치과용연고(미노사이클린염산염)미노씬캡슐50mg(미노사이클린염산염)ミノサイクリン塩酸塩点滴静注用100mg「NIG」ミノサイクリン塩酸塩点滴静注用100mg「日医工」ミノサイクリン塩酸塩点滴静注用100mg「サワイ」
Trang 1/4
Công ty đang bán Minocycline hydrochloride
동국
동국제약(주)Republic of KoreaSF
SUNSTAR FRANCEFranceSR
Shandong Ruiying Pharmaceutical Group Co., Ltd.ChinaHV
Hangzhou Verychem Science And Technology Co.Ltd.ChinaZM
Zhejiang Medicine Co., Ltd.ChinaCA
Chengdu Aupone Pharmaceutical Co.,Ltd.ChinaKH
Kyowa Hakko BioJapanTrang 1/3